Migraine
Multiple Sclerosis
Tardive dyskinesia
Events
Academy
About

Teva Corporate
Life Effects

See Neurologybytes around the World

Global

Global

International

Argentina
Australia
Brazil
Chile
Hong Kong
Israel
Mexico
Singapore
Thailand
US

Europe

Ireland
Spain
France
United Kingdom

Want to find out more about Teva's locations and phone numbers? Visit Teva Worldwide

Migraine
Multiple Sclerosis
Tardive dyskinesia
Events
Academy
About

Please note you are now leaving Neurologybytes.com and being redirected to a different website not operated by Teva Pharmaceuticals.

Continue

Congress

24.10.2017 - 27.10.2017 European Committee For Treatment & Research In Multiple Sclerosis

Multiple sclerosis -

6 min

What we learned on Wednesday (25 October) at ECTRIMS–ACTRIMS

Multiple sclerosis - Treatment

6 min

New approaches to clinical assessment of disability and cognition

Multiple sclerosis -

7 min

What we learned on Thursday (26 October) at ECTRIMS–ACTRIMS

Multiple sclerosis - Treatment

7 min

Insights that may inform optimal use of DMTs

ALL (0)

MIGRAINE (0)

MULTIPLE SCLEROSIS (0)

CONGRESS (0)

VIDEOS (0)

FOLLOW NEUROLOGYBYTES

Address

TEVA PHARMACEUTICALS EUROPE B.V.
BUSWEG 1
2031 DA HAARLEM
THE NETHERLANDS

Cookie settings

Job code

HQ/MED/17/0046

Date of preparation

Aug 2025

Reporting of suspected adverse events is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. To ensure correct adverse event reporting, healthcare professionals are encouraged to use the appropriate website for their National Authority.

Report Adverse Events